227 related articles for article (PubMed ID: 10768951)
1. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.
Schaefer DA; Auerbach-Dixon BA; Riggs MW
Infect Immun; 2000 May; 68(5):2608-16. PubMed ID: 10768951
[TBL] [Abstract][Full Text] [Related]
2. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
Enriquez FJ; Riggs MW
Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
[TBL] [Abstract][Full Text] [Related]
3. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.
Riggs MW; Stone AL; Yount PA; Langer RC; Arrowood MJ; Bentley DL
J Immunol; 1997 Feb; 158(4):1787-95. PubMed ID: 9029117
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.
Riggs MW; Schaefer DA; Kapil SJ; Barley-Maloney L; Perryman LE
Antimicrob Agents Chemother; 2002 Feb; 46(2):275-82. PubMed ID: 11796330
[TBL] [Abstract][Full Text] [Related]
5. Attempts to protect severe combined immunodeficient (scid) mice with antibody enriched for reactivity to Cryptosporidium parvum surface antigen-1.
Tatalick LM; Perryman LE
Vet Parasitol; 1995 Jul; 58(4):281-90. PubMed ID: 8533267
[TBL] [Abstract][Full Text] [Related]
6. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.
Riggs MW; Cama VA; Leary HL; Sterling CR
Infect Immun; 1994 May; 62(5):1927-39. PubMed ID: 8168959
[TBL] [Abstract][Full Text] [Related]
7. Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.
Omidian Z; Ebrahimzadeh E; Shahbazi P; Asghari Z; Shayan P
Parasitol Res; 2014 Jan; 113(1):229-37. PubMed ID: 24154594
[TBL] [Abstract][Full Text] [Related]
8. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.
Langer RC; Riggs MW
Infect Immun; 1999 Oct; 67(10):5282-91. PubMed ID: 10496907
[TBL] [Abstract][Full Text] [Related]
9. Polyclonal Fab phage display libraries with a high percentage of diverse clones to Cryptosporidium parvum glycoproteins.
Chen L; Williams BR; Yang CY; Cevallos AM; Bhat N; Ward H; Sharon J
Int J Parasitol; 2003 Mar; 33(3):281-91. PubMed ID: 12670513
[TBL] [Abstract][Full Text] [Related]
10. Protective monoclonal antibodies define a distinct, conserved epitope on an apical complex exoantigen of Cryptosporidium parvum sporozoites.
Riggs MW; Yount PA; Stone AL; Langer RC
J Eukaryot Microbiol; 1996; 43(5):74S-75S. PubMed ID: 8822870
[No Abstract] [Full Text] [Related]
11. Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum.
Askari N; Shayan P; Mokhber-Dezfouli MR; Ebrahimzadeh E; Lotfollahzadeh S; Rostami A; Amininia N; Ragh MJ
Parasite Immunol; 2016 May; 38(5):282-9. PubMed ID: 27012710
[TBL] [Abstract][Full Text] [Related]
12. Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid.
Riggs MW; McNeil MR; Perryman LE; Stone AL; Scherman MS; O'Connor RM
Infect Immun; 1999 Mar; 67(3):1317-22. PubMed ID: 10024577
[TBL] [Abstract][Full Text] [Related]
13. Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.
Matsubayashi M; Teramoto-Kimata I; Uni S; Lillehoj HS; Matsuda H; Furuya M; Tani H; Sasai K
J Biol Chem; 2013 Nov; 288(47):34111-34120. PubMed ID: 24085304
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivities with Cryptosporidium spp. by chicken monoclonal antibodies that recognize avian Eimeria spp.
Matsubayashi M; Kimata I; Iseki M; Lillehoj HS; Matsuda H; Nakanishi T; Tani H; Sasai K; Baba E
Vet Parasitol; 2005 Mar; 128(1-2):47-57. PubMed ID: 15725532
[TBL] [Abstract][Full Text] [Related]
15. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
[TBL] [Abstract][Full Text] [Related]
16. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.
Perryman LE; Kapil SJ; Jones ML; Hunt EL
Vaccine; 1999 Apr; 17(17):2142-9. PubMed ID: 10367947
[TBL] [Abstract][Full Text] [Related]
17. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.
Liu K; Zai D; Zhang D; Wei Q; Han G; Gao H; Huang B
Parasite Immunol; 2010 May; 32(5):335-44. PubMed ID: 20500662
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in cryptosporidiosis: the immune response.
Riggs MW
Microbes Infect; 2002 Aug; 4(10):1067-80. PubMed ID: 12191657
[TBL] [Abstract][Full Text] [Related]
19. Passive transfer of immunity against Cryptosporidium infection in neonatal mice using monoclonal antibodies.
Cho MH
Korean J Parasitol; 1993 Sep; 31(3):223-30. PubMed ID: 8241081
[TBL] [Abstract][Full Text] [Related]
20. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects.
Shirafuji H; Xuan X; Kimata I; Takashima Y; Fukumoto S; Otsuka H; Nagasawa H; Suzuki H
J Parasitol; 2005 Apr; 91(2):476-9. PubMed ID: 15986633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
